• Wed, April 16, 2025
  • Thu, April 17, 2025
  • Fri, April 18, 2025
  • Sat, April 19, 2025
  • Sun, April 20, 2025
  • Mon, April 21, 2025

J&J reports earnings beat as tariffs loom

Biotech news stories brought to you today by The Readout.
The article from STAT News dated April 15, 2025, discusses several significant developments in the biotech industry. Johnson & Johnson has acquired a new gene therapy platform from a startup, aiming to expand its capabilities in treating genetic disorders. Intra-Cellular Therapies reported positive results from a Phase 3 trial of Caplyta for treating bipolar depression, showing significant symptom improvement. Attovia Therapeutics announced a successful $100 million Series B funding round to advance its autoimmune disease treatments. Cytokinetics shared promising data from a study on its heart failure drug, suggesting potential improvements in patient outcomes. These updates highlight the ongoing innovation and investment in the biotech sector, focusing on gene therapy, mental health, autoimmune diseases, and cardiovascular treatments.

Read the Full STAT Article at:
https://www.statnews.com/2025/04/15/biotech-news-jj-intra-cellular-therapies-attovia-cytokinetics-caplyta-the-readout/

Like: 👍